Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 4.69% vs 1.36% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -69.40% vs 32.88% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 7.40% vs -21.61% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -10.00% vs 11.11% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Riken Vitamin Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -5.71% vs 5.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4.69% vs 1.36% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -57.94% vs 68.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -69.40% vs 32.88% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -41.32% vs 41.66% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 7.40% vs -21.61% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -10.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -10.00% vs 11.11% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






